Robert Mynatt, MD
Otolaryngology · Hixson, TNNPI 1891995940
Payments from drug & device makers
Across 32 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$138
- Stryker$109
- Regeneron Healthcare Solutions, Inc.$60
- Sanofi$57
- Kerecis Limited$45
- Integra Lifesciences Corporation$41
- plus $176 from 9 others
What the payments were for
- Food & beverage$624100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 7 | $138 |
| Stryker | 6 | $109 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Sanofi | 3 | $57 |
| Kerecis Limited | 2 | $45 |
| Integra Lifesciences Corporation | 1 | $41 |
| Intersect ENT, Inc. | 2 | $34 |
| Medtronic | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Acera Surgical, Inc. | 1 | $23 |
| Sanara Medtech Inc. | 2 | $20 |
| Merck | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| GSK | 1 | $13 |
| Aerin Medical Inc. | 1 | $8 |
How this compares
$624 in reported general payments places this provider in the 25th percentile of 191 otolaryngology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 30 | $3,313 |
| Ipratropium Bromide | 87 | $2,228 |
| Pantoprazole Sodium | 169 | $2,209 |
| Fluticasone Propionate | 93 | $954 |
| Ofloxacin | 31 | $906 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 58 | $592 |
| Methylprednisolone | 72 | $537 |
| Doxycycline Hyclate | 36 | $516 |
| Montelukast Sodium | 47 | $507 |
| Famotidine | 47 | $456 |
| Levothyroxine Sodium | 59 | $416 |
| Omeprazole | 27 | $372 |
| Hydrochlorothiazide | 32 | $313 |
| Azithromycin | 61 | $229 |
| Nystatin | 15 | $164 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Hixson
- Justin MorseHixson$5K
- Alexander SokohlHixson$3K
- Rakesh ChandraNashville$537K
- David FortuneHermitage$298K
- David KentNashville$195K
- Taha JanNashville$184K
- Marion GillespieMemphis$171K
- Naweed ChowdhuryNashville$151K
- Grady BryantHermitage$74K
- Clyde MathisonFarragut$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.